Diao X, Huestis MA. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites. Clinical Pharmacology and Therapeutics. February 2017, 101 (2): 239–253. PMID 27727455. S2CID 10910467. doi:10.1002/cpt.534.
Diao X, Huestis MA. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites. Clinical Pharmacology and Therapeutics. February 2017, 101 (2): 239–253. PMID 27727455. S2CID 10910467. doi:10.1002/cpt.534.
semanticscholar.org
api.semanticscholar.org
Diao X, Huestis MA. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites. Clinical Pharmacology and Therapeutics. February 2017, 101 (2): 239–253. PMID 27727455. S2CID 10910467. doi:10.1002/cpt.534.